<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02398227</url>
  </required_header>
  <id_info>
    <org_study_id>1R01MH095767</org_study_id>
    <nct_id>NCT02398227</nct_id>
  </id_info>
  <brief_title>Treatment of PTSD in Residents of Battered Women's Shelters</brief_title>
  <acronym>HOPE</acronym>
  <official_title>Treatment of PTSD in Residents of Battered Women's Shelters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Akron</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brown University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Summa Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kent State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pacific Institute for Research and Evaluation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Akron</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study comparing a new treatment (HOPE) to supportive therapy in the treatment of
      PTSD in residents of battered women's shelters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research suggests that approximately 1 in 4 women report a history of intimate partner
      violence (IPV), and IPV is associated with severe psychological problems, especially PTSD.
      Battered women's shelters annually provide emergency shelter to approximately 300,000 women
      and children. A prime time to intervene with IPV victims might be when they enter shelter and
      have already initiated a change in their life. Standard shelter care typically includes case
      management to help women access resources that can assist them in establishing long-term
      safety for themselves and their children. However, PTSD symptoms may compromise victims'
      ability to effectively use integral community resources, as well as their ability to
      appropriately react to threat relevant information, interfering with their ability to
      establish safety for themselves and their children. As such, research has found PTSD to be
      associated with re-abuse in victims of IPV.

      Despite the significant morbidity associated with IPV-related PTSD, our treatment, Helping to
      Overcome PTSD through Empowerment (HOPE), is the only extant treatment to date that has been
      developed to specifically target IPV-related PTSD in residents of battered women's shelters.
      Cognitive-behavioral treatments (CBT) for PTSD have been shown to be effective with multiple
      populations but do not address the unique needs of recent IPV victims. HOPE, a shelter-based,
      individual, brief CBT treatment for PTSD in victims of IPV, addresses IPV victims' current
      needs of safety, self-care, protection, and empowerment, as well as the exchange of
      information on PTSD symptoms and how these symptoms interfere with the use of shelter and
      community resources and their ability to establish safety. HOPE was specifically designed to
      serve as an evidence-based model program that could be implemented in a wide-range of shelter
      programs across the United States. The current proposal builds on the foundation of our
      NIMH-funded treatment development study (R34MH080786). Pilot work with HOPE supports the
      initial acceptability and feasibility of this new treatment. IPV victims who received a
      significant dose of HOPE were 12 times less likely than women received only standard shelter
      services to report being re-abused after leaving shelter. Further, women who received HOPE
      displayed fewer PTSD arousal and avoidance symptoms of PTSD, less depression, and greater
      social support and empowerment relative to women who did not receive HOPE. The overall aim of
      this project is to test the efficacy of HOPE relative to supportive therapy (i.e., Present
      Centered Therapy, PCT) in a sample of 186 female residents of battered women's shelters with
      IPV-related PTSD. In an effort to facilitate future dissemination of HOPE, sessions will be
      delivered by community therapists and the study will be conducted in a range of shelter
      systems. Furthermore, the current proposal, unlike the pilot study, will compare HOPE to an
      attention matched control condition, have a longer follow-up period, will assess the impact
      of HOPE on child abuse potential, and will incorporate objective measures of stress
      responding (e.g., attentional biases and physiological reactivity to trauma cues), explore
      mediators and moderators of treatment, and evaluate the cost effectiveness of HOPE.

      The Specific Aim of this proposal is to conduct a randomized controlled trial comparing HOPE
      to PCT in residents of battered women shelters with IPV-related PTSD. The study will test the
      following hypotheses:

      Primary Hypotheses: HOPE will be significantly more efficacious than PCT in reducing
      participants' IPV-related PTSD symptoms and severity of re-abuse over a one-year follow-up.

      Secondary Hypotheses: Associated Symptoms, Psychosocial Functioning, and Cost:

        -  HOPE will be significantly more efficacious than PCT in decreasing participants'
           depressive symptoms and child abuse potential; in increasing participants' degree of
           empowerment, quality of life, degree and quality of social support, effective use of
           resources, and traumatic cognitions over a one-year follow-up.

        -  Shelter residents who receive HOPE will display reduced biases in attention to
           threat-related information and normalization of physiological reactivity to trauma cues,
           relative to women who receive PCT over a one-year follow-up.

        -  We also plan to evaluate the cost-effectiveness of HOPE measured by cost per quality
           adjusted life year saved (QULY).

      We will also explore the following hypotheses regarding potential mediators and moderators of
      HOPE:

        -  The effect HOPE has on PTSD over the one-year follow-up will be mediated by
           participants' degree of empowerment, effective use of resources, and traumatic
           cognitions at post-treatment.

        -  HOPE participants' PTSD symptoms post-treatment will mediate participants' severity of
           re-abuse over the one-year follow-up period.

        -  We also plan to explore whether the following baseline variables are moderators of
           treatment response: minority status, IPV and PTSD severity, attentional biases to threat
           related information, and physiological reactivity to trauma cues.

      HOPE, a novel treatment for battered women with IPV-related PTSD, has the potential to
      provide a national model of care for a vulnerable, underserved, and understudied population.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinician Administered PTSD Scale (CAPS)</measure>
    <time_frame>baseline, post-shelter, post-treatment, 6 months post-treatment, 1 year post-treatment</time_frame>
    <description>Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity Adjusted means with baseline scores as a covariate are reported</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of Violence Against Women Scale (SVAWS)</measure>
    <time_frame>baseline, post-shelter, post-treatment, 6-month post-treatment, 1 year post-treatment</time_frame>
    <description>Severity of Violence Against Women Scale total score. Scores can range from 0 to 138 with higher scores reflecting greater degree of violence/abuse.Adjusted means with baseline scores as a covariate are reported</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">172</enrollment>
  <condition>PTSD</condition>
  <arm_group>
    <arm_group_label>HOPE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cognitive Behavioral Treatment Program for PTSD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Present Centered Therapy for PTSD</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HOPE</intervention_name>
    <description>Cognitive Behavioral Treatment for PTSD in Battered Women</description>
    <arm_group_label>HOPE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PCT</intervention_name>
    <description>Present Centered Therapy for PTSD</description>
    <arm_group_label>PCT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must be resident in one of the 6 participating shelters,

          -  IPV in month prior to shelter,

          -  PTSD

        Exclusion Criteria:

          -  substance dependence in last 3 months,

          -  change in meds in last month,

          -  Bipolar d/o,

          -  psychosis,

          -  active suicidality
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawn M Johnson, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Akron</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44325</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>May 28, 2013</study_first_submitted>
  <study_first_submitted_qc>March 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2015</study_first_posted>
  <results_first_submitted>June 19, 2018</results_first_submitted>
  <results_first_submitted_qc>August 9, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">August 10, 2018</results_first_posted>
  <last_update_submitted>August 9, 2018</last_update_submitted>
  <last_update_submitted_qc>August 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Akron</investigator_affiliation>
    <investigator_full_name>Dawn Johnson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Battered Women</keyword>
  <keyword>Trauma</keyword>
  <keyword>Domestic Violence</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 6, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT02398227/ICF_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 25, 2011</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT02398227/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HOPE</title>
          <description>Cognitive Behavioral Treatment Program for PTSD
HOPE: Cognitive Behavioral Treatment for PTSD in Battered Women</description>
        </group>
        <group group_id="P2">
          <title>Present Centered Therapy (PCT)</title>
          <description>Present Centered Therapy for PTSD
PCT: Present Centered Therapy for PTSD</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="83"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="56"/>
                <participants group_id="P2" count="71"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Removed from treatment and dropped out</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HOPE</title>
          <description>Cognitive Behavioral Treatment Program for PTSD
HOPE: Cognitive Behavioral Treatment for PTSD in Battered Women</description>
        </group>
        <group group_id="B2">
          <title>Present Centered Therapy (PCT)</title>
          <description>Present Centered Therapy for PTSD
PCT: Present Centered Therapy for PTSD</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="83"/>
            <count group_id="B2" value="89"/>
            <count group_id="B3" value="172"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="172"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.5" lower_limit="19" upper_limit="59"/>
                    <measurement group_id="B2" value="36" lower_limit="19" upper_limit="59"/>
                    <measurement group_id="B3" value="35.13" lower_limit="19" upper_limit="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="172"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="87"/>
                    <measurement group_id="B3" value="167"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinician-Administered PTSD Scale (CAPS)</title>
          <description>Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.11" spread="20.87"/>
                    <measurement group_id="B2" value="77.82" spread="21.12"/>
                    <measurement group_id="B3" value="75.06" spread="21.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinician Administered PTSD Scale (CAPS)</title>
        <description>Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity Adjusted means with baseline scores as a covariate are reported</description>
        <time_frame>baseline, post-shelter, post-treatment, 6 months post-treatment, 1 year post-treatment</time_frame>
        <population>Analysis include those participants who completed each follow-up time point.</population>
        <group_list>
          <group group_id="O1">
            <title>HOPE</title>
            <description>Cognitive Behavioral Treatment Program for PTSD
HOPE: Cognitive Behavioral Treatment for PTSD in Battered Women</description>
          </group>
          <group group_id="O2">
            <title>Present Centered Therapy (PCT)</title>
            <description>Present Centered Therapy for PTSD
PCT: Present Centered Therapy for PTSD</description>
          </group>
        </group_list>
        <measure>
          <title>Clinician Administered PTSD Scale (CAPS)</title>
          <description>Clinical Interview assessing symptoms of Posttraumatic Stress Disorder (PTSD) scores can range from 0 to 136 with higher scores reflecting greater PTSD severity Adjusted means with baseline scores as a covariate are reported</description>
          <population>Analysis include those participants who completed each follow-up time point.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="70"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-shelter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.08" spread="25.36"/>
                    <measurement group_id="O2" value="52.39" spread="28.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.75" spread="22.47"/>
                    <measurement group_id="O2" value="34.43" spread="28.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.36" spread="28.36"/>
                    <measurement group_id="O2" value="32.63" spread="27.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.32" spread="24.96"/>
                    <measurement group_id="O2" value="29.00" spread="28.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.968</p_value>
            <method>ANCOVA</method>
            <method_desc>p value reported for overall effect across all-time points between treatment arms</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Severity of Violence Against Women Scale (SVAWS)</title>
        <description>Severity of Violence Against Women Scale total score. Scores can range from 0 to 138 with higher scores reflecting greater degree of violence/abuse.Adjusted means with baseline scores as a covariate are reported</description>
        <time_frame>baseline, post-shelter, post-treatment, 6-month post-treatment, 1 year post-treatment</time_frame>
        <population>Analysis only include those who completed all time-points</population>
        <group_list>
          <group group_id="O1">
            <title>HOPE</title>
            <description>Cognitive Behavioral Treatment Program for PTSD
HOPE: Cognitive Behavioral Treatment for PTSD in Battered Women</description>
          </group>
          <group group_id="O2">
            <title>Present Centered Therapy (PCT)</title>
            <description>Present Centered Therapy for PTSD
PCT: Present Centered Therapy for PTSD</description>
          </group>
        </group_list>
        <measure>
          <title>Severity of Violence Against Women Scale (SVAWS)</title>
          <description>Severity of Violence Against Women Scale total score. Scores can range from 0 to 138 with higher scores reflecting greater degree of violence/abuse.Adjusted means with baseline scores as a covariate are reported</description>
          <population>Analysis only include those who completed all time-points</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-shelter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.81" spread="15.37"/>
                    <measurement group_id="O2" value="13.89" spread="28.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.47" spread="8.82"/>
                    <measurement group_id="O2" value="1.10" spread="3.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-month post-shelter</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.42" spread="13.51"/>
                    <measurement group_id="O2" value="2.73" spread="8.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1-year post-treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.40" spread="9.03"/>
                    <measurement group_id="O2" value="3.68" spread="12.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.560</p_value>
            <method>ANCOVA</method>
            <method_desc>p value reported for overall effect across all-time points between treatment arms</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12-month follow-up.</time_frame>
      <desc>12-month follow up.</desc>
      <group_list>
        <group group_id="E1">
          <title>HOPE</title>
          <description>Cognitive Behavioral Treatment Program for PTSD
HOPE: Cognitive Behavioral Treatment for PTSD in Battered Women</description>
        </group>
        <group group_id="E2">
          <title>Present Centered Therapy (PCT)</title>
          <description>Present Centered Therapy for PTSD
PCT: Present Centered Therapy for PTSD</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Serious, Other</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Significant Clinical Deterioration Suicidality</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="83"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Active Homicidality</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Psychiatric Inpatient Hospitalization</sub_title>
                <counts group_id="E1" events="13" subjects_affected="10" subjects_at_risk="83"/>
                <counts group_id="E2" events="18" subjects_affected="12" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Life Threatening Experience or Trauma</sub_title>
                <counts group_id="E1" events="58" subjects_affected="28" subjects_at_risk="83"/>
                <counts group_id="E2" events="79" subjects_affected="33" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Life Threatening Experience and Sexual Assault</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="12" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Hospitalization Related to Domestic Violence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="9" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Other Hospitalization</sub_title>
                <counts group_id="E1" events="49" subjects_affected="25" subjects_at_risk="83"/>
                <counts group_id="E2" events="62" subjects_affected="29" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Receipt of a Serious Health Diagnosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="83"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Sexual Assault</sub_title>
                <counts group_id="E1" events="29" subjects_affected="12" subjects_at_risk="83"/>
                <counts group_id="E2" events="21" subjects_affected="9" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Reporting to Children's Services</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="83"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Criminal Charge or Arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Persistent or Significant Disability or Impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pregnancy Complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_vocab>Serious, Other</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="83"/>
                <counts group_id="E2" subjects_affected="76" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Substance Use</sub_title>
                <counts group_id="E1" events="16" subjects_affected="12" subjects_at_risk="83"/>
                <counts group_id="E2" events="15" subjects_affected="12" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Significant Clinical Deterioration CAPS</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Non-life Threatening Abuse or Trauma</sub_title>
                <counts group_id="E1" events="297" subjects_affected="74" subjects_at_risk="83"/>
                <counts group_id="E2" events="280" subjects_affected="73" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Confidentiality Breach</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dawn M Johnson, Ph.d</name_or_title>
      <organization>University of Akron</organization>
      <phone>3309722505</phone>
      <email>johnsod@uakron.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

